The Challenge of Change - Managing Excipients Control
Colorcon
08-Feb-2011 - Eli Lilly will factor the performance of candidate drugs into employee bonuses in future under a scheme designed to stress the importance of R&D.
08-Feb-2011 - US drug giant Merck & Co has ended its strategic drug discovery and development alliance with Belgian biotechnology firm Galapagos.
08-Feb-2011 - More collaborative biosurveillance could save billions of dollars and millions of lives by, for example, cutting pandemic strain isolation times.
07-Feb-2011 - Pfizer has acquired the consumer healthcare business of Danish firm Ferrosan for an undisclosed fee in what the pharma giant says, “is an excellent strategic fit that strengthens our presence in dietary supplements”.
07-Feb-2011 - Israeli drugmaker Teva Pharmaceutical Industries has received a US FDA warning letter criticising laboratory operations at its manufacturing facility in Jerusalem.
07-Feb-2011 - Lotus Pharmaceuticals’ new HQ in Beijing, China will be even bigger after the firm announces plans for employee apartments.
07-Feb-2011 - Biopharm manufacturers should hold a volume of buffer stock to ensure it can maintain supply during fluctuations in demand, says UK guidance.
03-Feb-2011 - Ugandan drugmaker Quality Chemicals Industries (QCI) will invest $80m in manufacturing operations to boost capacity for the production of generic AIDS and malaria drugs.
02-Feb-2011 - US drug giant Pfizer will close an R&D centre in the UK with the loss of 2,400 jobs to help save $5bn a year by 2012.
02-Feb-2011 - Canada’s Valeant Pharmaceuticals will pay €350m for PharmaSwiss to expand its presences in the central and eastern European generic drug market.
01-Feb-2011 - Supply chain strategy implementations are more likely to succeed when they have the active support of the board and senior executives, according to research.
01-Feb-2011 - German drugmaker Bayer has set its sights on expanding in the Indian drug market with the formation of a new joint venture with Zydus Cadila.
01-Feb-2011 - in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at the USP, PDA and Merck KGaA.
31-Jan-2011 - Arena Pharmaceutical will cut its workforce by 25 per cent as it refocuses to try and win US approval for its weight management drug Lorcaserin.
31-Jan-2011 - The European Parliament’s Socialist and Democrats (S&D) group wants to ban the export of drugs used to execute death row inmates.
27-Jan-2011 - Irish drugmaker Elan has confirmed that it has axed 130 jobs, reducing its workforce by 10 per cent.
26-Jan-2011 - GSK and Teva will invest in Russian drug manufacturing in response to PM Vladimir Putin’s warning that Pharmas will face restrictions if they fail to boost local production and transfer technology.
26-Jan-2011 - PsiOxus Therapeutics has predicted growing demand for oncolytic vaccines, citing recent industry acquisitions as evidence of the need for novel treatments for cancer.
26-Jan-2011 - Russian drugmaker Pharmsynthez has bought Estonian manufacturer Kevelt in a bid to expand its international business.
26-Jan-2011 - in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including a new job for former FDA chief and Catalent packaging appointments.
25-Jan-2011 - Affygility Solutions has launched a new smartphone app designed to let life science EHS’ to access compliance requirements in real-team.
24-Jan-2011 - One employee has died and two have been injured after an incident at Baxter International’s manufacturing facility in Atwater, California last weekend.
24-Jan-2011 - Genzyme will build a second manufacturing plant in Geel, Belgium to ensure it has the capacity to meet demand for its Pompe disease drugs Myozyme and Lumizyme.
19-Jan-2011 - in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including a new job for former EMA chief and Catalent strengthening its production team.
18-Jan-2011 - GSK has set aside an additional £2.2bn ($3.4bn) to cover anticipated Q4 legal costs related to a US investigation of its diabetes drug Avandia.